Dasatinib Dosing & DREAMseq
Dec 02, 2021•20 min
Episode description
Lots of updates to discuss from dasatinib dosing to ICI/TKI sequencing in BRAF-mutated metastatic melanoma to adjuvant chemo in node (+) breast cancer to some FDA approval updates.
For the best experience, listen in Metacast app for iOS or Android
